Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Therapy crawled time : 14:15 save search
Precision BioSciences to Highlight Capabilities of ARCUS Gene Editing for Allogeneic CAR T Cell Immunotherapies at The Society for Immunotherapy of Cancer 36th Annual Meeting
Published: 2021-11-09 (Crawled : 14:15) - biospace.com/
DTIL | $9.81 -4.11% -4.28% 34K
|
Health Technology
|
| O: -2.04%
H: 0.0%
C: 0.0%
immunotherapy therapy cancer arcus car-t t-cell
Cellenkos® Inc. Secures $15 Million Series A Financing to Accelerate the Development of Transformation Cell-Based Therapies
Published: 2021-11-04 (Crawled : 14:15) - prnewswire.com
INCY | $51.72 0.14% 0.14% 1.5M
|
Health Technology
|
| O: 2.41%
H: 0.0%
C: 0.0%
therapy
Multimeric Anti-DR5 IgM Agonist Antibody IGM-8444 Is a Potent Inducer of Cancer Cell Apoptosis and Synergizes with Chemotherapy and BCL-2 Inhibitor ABT-199
Published: 2021-10-28 (Crawled : 14:15) - igmbio.com
IGMS | $7.95 3.25% 3.14% 690K
|
Health Technology
|
| O: 0.37%
H: 3.74%
C: 3.25%
therapy cancer antibody
Intellia Therapeutics and SparingVision Announce Strategic Collaboration to Develop Novel Ocular Therapies Using CRISPR/Cas9 Technology
Published: 2021-10-13 (Crawled : 14:15) - biospace.com/
NTLA | $21.16 -1.72% -1.75% 860K
|
Health Technology
|
| O: -0.68%
H: 2.19%
C: -1.46%
crispr ocular collaboration technology therapy
Continuous Renal Replacement Therapy (CRRT) Market size worth $1.8 Billion, Globally, by 2028 at 6.3% CAGR: Verified Market Research®
Published: 2021-10-12 (Crawled : 14:15) - prnewswire.com
MDT | $80.38 -1.12% 0.0% 5M
|
Health Technology
|
| O: 0.2%
H: 0.17%
C: -0.69%
BAX | $40.93 -0.22% 0.0% 2.1M
|
Health Technology
|
| O: -0.11%
H: 0.25%
C: -0.15%
renal therapy research
Poseida Therapeutics Announces Research Collaboration with Takeda for Novel Non-Viral In Vivo Gene Therapies
Published: 2021-10-12 (Crawled : 14:15) - biospace.com/
TAK | News | $13.23 -1.12% 0.0% 920K
|
Health Technology
|
| O: 0.21%
H: 0.14%
C: -1.05%
PSTX | $2.065 -4.4% -4.6% 350K
|
Health Technology
|
| O: 5.26%
H: 0.5%
C: -4.57%
gene therapies collaboration research gene therapy therapy
CRISPR Therapeutics to Present Preclinical Data at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting
Published: 2021-10-01 (Crawled : 14:15) - biospace.com/
CRSP | News M | $55.66 -1.33% -1.35% 910K
|
Health Technology
|
| O: -0.16%
H: 0.57%
C: -0.41%
crispr immunotherapy therapy cancer preclinical pre-clinical
Oncorus to Present Initial Data from its Ongoing Phase 1 Clinical Trial of ONCR-177 at the Upcoming Society for Immunotherapy of Cancer’s (SITC) 36th Annual Meeting
Published: 2021-10-01 (Crawled : 14:15) - biospace.com/
ONCR | $0.126 -75.95% 140K
|
Health Technology
|
| O: -0.11%
H: 1.61%
C: 0.21%
immunotherapy ongoing phase 1 therapy cancer trial
ALX Oncology Announces Four Abstracts Accepted for Presentation at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting
Published: 2021-10-01 (Crawled : 14:15) - biospace.com/
ALXO M | $16.24 4.77% 4.56% 440K
|
Commercial Services
|
| O: -0.31%
H: 1.71%
C: 1.05%
presentation immunotherapy therapy cancer
Atreca Announces Poster Presentations at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
Published: 2021-10-01 (Crawled : 14:15) - biospace.com/
BCEL P | $0.08 0.0% 160K
|
Health Technology
|
| O: -1.12%
H: 2.11%
C: -0.65%
presentation immunotherapy therapy cancer
Tempest Announces Presentation at the Society for Immunotherapy of Cancer (SITC) 36th Annual Meeting
Published: 2021-10-01 (Crawled : 14:15) - biospace.com/
TPST | $3.43 0.29% 0.29% 650K
|
Manufacturing
|
| O: 0.48%
H: 4.59%
C: 3.85%
presentation immunotherapy pest therapy cancer
Global Induced Pluripotent Stem Cell (iPSC) Market Report 2021: Focus on Drug Discovery & Toxicity Studies, Academic Research, Cell & Gene Therapy, Regenerative Medicine - Forecast to 2030
Published: 2021-09-14 (Crawled : 14:15) - prnewswire.com
TMO | News | $577.39 0.49% 0.0% 2M
|
Health Technology
|
| O: 0.73%
H: 0.52%
C: -0.14%
stem cell gene therapy therapy drug discovery drug research gene therapies
Tryp Therapeutics Completes Psychotherapy Training for Phase 2a Study at the University of Florida
Published: 2021-08-24 (Crawled : 14:15) - biospace.com/
EIX | $70.82 -0.04% 0.0% 3.7M
|
Utilities
|
| O: 0.32%
H: 0.0%
C: -0.67%
phase 2 therapy phase 2b train
Taysha Gene Therapies to Host Key Opinion Leader Webinar on TSHA-118 for the Treatment of CLN1 Disease
Published: 2021-08-17 (Crawled : 14:15) - biospace.com/
TSHA | $2.355 -6.92% -7.43% 790K
|
Health Technology
|
| O: 0.0%
H: 14.91%
C: 10.62%
disease treatment gene therapies gene therapy therapy
Radiotherapy Market Size to Reach USD 7.65 Billion in 2027 | Increasing Global Incidence of Cancer, Rising Use of Radiotherapy in Combination with Other Treatment Approaches are Some Key Factors Driving Industry Demand, says Emergen Research
Published: 2021-08-11 (Crawled : 14:15) - prnewswire.com
VRAY | $0.025 -39.9% -61.87% 110M
|
Health Technology
|
| O: 0.0%
H: 0.67%
C: -4.88%
ARAY | $2.2 -0.9% -0.91% 290K
|
Health Technology
|
| O: -0.5%
H: 0.0%
C: -1.0%
treatment therapy cancer research iot merge
Global Gene Therapy Market to Reach $2.7 Billion by 2026
Published: 2021-06-29 (Crawled : 14:15) - prnewswire.com
QURE | $4.57 -3.79% -3.94% 640K
|
Health Technology
|
| O: 0.1%
H: 1.22%
C: -0.26%
SRPT | $124.27 6.11% 5.75% 1.3M
|
Health Technology
|
| O: 0.0%
H: 0.25%
C: -2.43%
SGMO | News | $0.4911 -5.72% -6.07% 1.2M
|
Health Technology
|
| O: -0.91%
H: 1.08%
C: -2.66%
RGNX | $16.05 0.94% 0.93% 350K
|
Health Technology
|
| O: -0.26%
H: 1.59%
C: -1.13%
ORTX | $16.7 0.0% 370K
|
Health Technology
|
| O: 1.13%
H: 0.1%
C: -8.26%
NTLA | $21.16 -1.72% -1.75% 860K
|
Health Technology
|
| O: -2.19%
H: 17.95%
C: 16.17%
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: -0.04%
H: 0.53%
C: 0.38%
EDIT | News | $5.355 -1.92% -1.96% 1.6M
|
Health Technology
|
| O: 2.07%
H: 3.99%
C: 2.67%
CRSP | News M | $55.66 -1.33% -1.35% 910K
|
Health Technology
|
| O: -0.41%
H: 1.48%
C: -0.34%
BLUE | $0.9274 -4.45% -4.66% 8.1M
|
Health Technology
|
| O: -0.26%
H: 0.64%
C: -3.25%
AGTC | News | $0.3936 1.23% 0.0%
|
Health Technology
|
| O: 1.49%
H: 0.0%
C: -2.44%
ALNY | $143.8 -1.55% -1.58% 390K
|
Health Technology
|
| O: 0.42%
H: 0.15%
C: -0.62%
ADAP | $1.085 -4.83% -5.07% 780K
|
Health Technology
|
| O: -0.68%
H: 1.6%
C: 0.23%
ABEO | News | $3.165 -7.19% -7.74% 2.2M
|
Health Technology
|
| O: 0.0%
H: 0.59%
C: -2.96%
gene therapy therapy gene therapies market
Oncologists have grown more comfortable with CAR-T therapy, research finds
Published: 2021-06-03 (Crawled : 14:15) - biospace.com/
CAH | $103.54 0.16% 0.0% 2.1M
|
Distribution Services
|
| O: -0.53%
H: 1.3%
C: 0.82%
therapy car-t research
Sio Gene Therapies Announces Four Upcoming Oral Presentations at the 24th Annual Meeting of the American Society of Gene and Cell Therapy
Published: 2021-04-28 (Crawled : 14:15) - biospace.com/
SIOX | $0.478 -20.5% 40K
|
Health Technology
|
| O: 0.78%
H: 8.14%
C: 3.88%
presentation gene therapies therapy gene therapy
Gamma Delta T Cell Cancer Immunotherapy Clinical Research Trials Pipeline Outlook 2026
Published: 2021-04-23 (Crawled : 14:15) - prnewswire.com
ARVL | News | $0.49 0.37% 2.5M
|
Manufacturing
|
| O: 3.38%
H: 10.07%
C: 9.93%
immunotherapy therapy cancer research trial t-cell
Abbott's XIENCE™ Stent Receives European Approval for One-Month Dual Anti-Platelet Therapy (DAPT) for High Bleeding Risk Patients
Published: 2021-04-06 (Crawled : 14:15) - biospace.com/
ABT | News | $106.9 -0.64% 0.0% 5.1M
|
Health Technology
|
| O: 0.13%
H: 1.67%
C: -0.03%
risk bleeding therapy approval
Gainers vs Losers
| 65% | 35% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 210M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.